OpGen

OpGen Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of OpGen (OPGN) as of Oct 19, 2026 is -5.01 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -40.61 % — a change of -87.66% (higher).

Cash Conversion

-5.01 %

YoY

-87.66%

Last updated:

Cash Conversion Rate (OCF/Net Income) of OpGen is 2025 -5.01 % . Cash Conversion Rate (OCF/Net Income) of OpGen was 2024 -40.61 % . It decreases by -87.66% higher compared to the previous year.

The OpGen Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
82.84 USD
Jan 1, 2019
92.44 USD
Jan 1, 2020
89.26 USD
Jan 1, 2021
61.71 USD
Jan 1, 2022
54.85 USD
Jan 1, 2023
43.83 USD
Jan 1, 2024
-40.61 USD
Jan 1, 2025
-5.01 USD
The OpGen Cash Conversion history
YEARCash ConversionYoY
-5.01 %-87.66%
-40.61 %-192.64%
43.83 %-20.09%
54.85 %-11.12%
61.71 %-30.87%
89.26 %-3.44%
92.44 %+11.59%
82.84 %-10.85%
92.93 %+3.25%
90.00 %+9.38%
82.28 %-13.35%
94.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Cash Conversion Rate (OCF/Net Income) of OpGen is -5.01 % in 2025.

Cash Conversion Rate (OCF/Net Income) of OpGen changed from -40.61 % to -5.01 %, representing a -87.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) OpGen since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s OpGen with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — OpGen

All Key Metrics — OpGen